concurrent chemoradiotherapy
To study the role of diffusion weighted MRI in predicting response to concurrent chemoradiotherapy or radical radiotherapy in locally advanced laryngeal and hypopharyngeal malignancy as part of the organ preservation protocol
... with concurrent weekly Cisplatin (40 mg/m2) or weekly Nimotuzumab spanning over 6 -7 ...with concurrent chemoradiotherapy or biological agents including ...
114
A systematic comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages between concurrent chemoradiotherapy and sequential chemotherapy
... by radiotherapy versus concurrent chemoradiotherapy in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type. Preliminary outcome of concurrent chemoradiation [r] ...
7
Comparative effectiveness of image-guided radiotherapy for non-operated localized esophageal squamous cell carcinoma patients receiving concurrent chemoradiotherapy: A population- based propensity score matched analysis
... ABSTRACT Background: Although concurrent chemoradiotherapy CCRT coupled with imageguided radiotherapy IGRT is associated with a theoretical benefit in non-operated localized esophageal s[r] ...
8
Cisplatin concurrent chemoradiotherapy vs adjuvant radiation in stage IB/IIA cervical cancer with intermediate risk factors, treated with radical surgery: a retrospective study
... alone, concurrent chemoradiotherapy (CCRT) increased the 4-year overall survival (OS) from 71% to 80% and improved the 4-year progress-free survival (PFS) from 63% to ...
7
Concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of head and neck with capecitabine and weekly cisplatin
... 61 chemoradiotherapy with Capecitabine and cisplatin in patients with locally advanced ...the chemoradiotherapy, CR was attained in ...respectively. Concurrent chemoradiotherapy with ...
166
<p>Nimotuzumab Combined with Induction Chemotherapy and Concurrent Chemoradiotherapy in Unresectable Locally Advanced Hypopharyngeal Carcinoma: A Single Institution Experience in China</p>
... and concurrent chemoradiotherapy, but the cost of nimotuzumab is higher than ordinary cancer medicines, and for hypopharyngeal cancer, it is not covered by national basic medical insurance; therefore, some ...
7
A retrospective study of concurrent chemoradiotherapy plus S-1 adjuvant chemotherapy on curative effect for treatment of patients with N3 stage nasopharyngeal carcinoma
... of concurrent chemotherapy and 4 cycles of adjuvant ...of concurrent chemotherapy) and general-fading group (the rest of the ...NPC, concurrent chemoradiotherapy plus S-1 adjuvant chemotherapy ...
7
Case Report Nasopharyngeal primitive neuroectodermal tumor after concurrent chemoradiotherapy for nasopharyngeal carcinoma: a case report
... Abstract: Objectives Primitive neuroectodermal tumors (PNETs) belong to the class of malignant small round cell tu- mors and are highly aggressive with rapid growth. PNETs occurring in the nasopharynx are extremely rare. ...
5
The role of induction and adjuvant chemotherapy in combination with concurrent chemoradiotherapy for nasopharyngeal cancer: a Bayesian network meta-analysis of published randomized controlled trials
... Abstract: Whether the addition of induction chemotherapy (IC) or adjuvant chemotherapy (AC) to concurrent chemoradiotherapy (CCRT) is superior to CCRT alone for locally advanced nasopharyngeal cancer is ...
12
Original Article CREPT is a novel predictor of the response to adjuvant therapy or concurrent chemoradiotherapy in esophageal squamous cell carcinoma
... Abstract: CREPT has been shown to be highly expressed in most tumors and is associated with a poor prognosis, but the histologic characteristics of CREPT expression and its impact on clinical outcomes in esophageal ...
11
Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method
... Patients and methods: A retrospective review was conducted of 255 NPC patients treated with NCT+CCRT (n=67) or CCRT alone (n=188) based on IMRT between December 2006 and December 2012. To control the imbalance, a 1:2 ...
13
Original Article New-onset anastomotic leakage is not associated with changes in preoperative nutritional status induced by concurrent chemoradiotherapy in esophageal cancer patients
... with concurrent chemoradiotherapy (CCR) for esophageal cancer, and the possible association between preoperative nutritional status and occurrence of anastomotic ...
6
Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
... We feel that our findings are compatible with the prevalent concept that esophagectomy is an integral part of treatment for locally advanced esophageal cancer [1], possibly through improved disease control (demon- ...
8
Radiotherapy with neoadjuvant chemotherapy versus concurrent chemoradiotherapy for ascending-type nasopharyngeal carcinoma: a retrospective comparison of toxicity and prognosis
... [25–28]. Improved locoregional control was anticipated with improved dose coverage of GTV and CTV. There- fore, the effect of chemotherapy on locoregional control in NPC patients treated with IMRT remained uncer- tain. ...
8
Surgery with versus without preoperative concurrent chemoradiotherapy for mid/low rectal cancer: an interim analysis of a prospective, randomized trial
... In China, colorectal cancer is the fifth most common can- cer in male and the third most common cancer in female [1]. In 2014, 40,000 new cases of rectal cancer (23,380 male cases and 16,620 female cases) and 50,310 ...
10
Emerging treatment options for nasopharyngeal carcinoma
... meta-analyses, concurrent cisplatin-based chemoradiotherapy is the current standard of care for locally advanced disease (American Joint Committee on Cancer manual [7th edition] stages ...+ ...
16
Download Download PDF
... or concurrent chemoradiotherapy ...received concurrent cisplatin-based chemotherapy (CT) including 18 patients who also received neoadjuvant ...with concurrent CT is well-tolerated and may ...
9
Does Surgery Have a Relevant Role in the Primary Treatment of Locoregionally Advanced Oropharyngeal Carcinomas?
... by concurrent chemoradiotherapy and concurrent chemoradiotherapy ...by concurrent chemoradiotherapy and 40 patients were treated only with concurrent ...after ...
8
A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
... respectively, and the local recurrence rate of patients who undergo waiting for observation after CCR was 31% [66]. Therefore caution needs to be taken in waiting and observing strategy and non-operative treatment on the ...
10
Use of 18F-FDG PET/CT Imaging for Radiotherapy Target Volume Delineation after Induction Chemotherapy and for Prognosis of Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN)
... patients with locally advanced squamous cell carcinoma of the head and neck receiving 401. sequential induction chemotherapy followed by concurrent chemoradiotherapy[r] ...
16